← Eichor
Study identifier: NCT02315729 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis

Condition: Adolescent Idiopathic Scoliosis  ·  Sponsor: University of Colorado, Denver

PhaseN/A
Planned participants380
Who can joinFemale, 10 Years to 13 Years
Healthy volunteersNo

About this study

The purpose of this study is to identify potential markers for curve progression in adolescent idiopathic scoliosis (AIS). Despite its prevalence and impact on child health, the etiology of AIS and molecular mechanisms underlying its development and progression remain poorly understood. Clinical criteria and features cannot adequately predict which children, diagnosed with mild disease, will undergo subsequent curve progression requiring intervention. The investigators hypothesize that alterations in specific genetic markers will be correlated with the progression of AIS curves over time. Thus, these markers could be used in the future to develop a reliable, inexpensive and relatively non-invasive cell based diagnostic test to (1) predict spinal curve progression in AIS, (2) select patients likely to benefit from early surgical intervention, and (3) potentially screen for asymptomatic children at risk of developing idiopathic scoliosis.

This description comes directly from the study's public registry record.

Talk to the study team

jiandong hao  ·  303-724-7457  ·  jiandong.hao@cuanschutz.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Children'S Hospital of ColoradoDenver, Colorado, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02315729